ArticleAdvances in therapy2026

Comparative Efficacy of Talquetamab vs. Real-World Physician's Choice of Treatment in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: Updated Analyses of MonumenTAL-1 vs. LocoMMotion/MoMMent.

Hermann Einsele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.